VOGLICARE M 0.3 (Metformin (500mg) + Voglibose (0.3mg))

Voglicare-M 0.3 Tablet ER is classified as an anti-diabetic medication utilized in the management of type 2 diabetes mellitus in adult patients. This medication comprises a combination of active ingredients aimed at effectively regulating blood glucose levels for those diagnosed with diabetes. It is crucial to take Voglicare-M 0.3 Tablet ER in conjunction with food to enhance its efficacy. Consistency in timing is essential; therefore, it is advisable to administer the medication at the same time each day to maximize its benefits. The prescribing physician determines the appropriate dosage, which may be adjusted periodically based on the patient’s blood glucose readings and overall response to therapy. Continuation of this medication is important even when the individual feels well, as ceasing its use abruptly can lead to increased blood sugar levels. Such a spike poses risks of severe complications, including kidney impairment, vision loss, neuropathy, and potential limb loss. This medication should be integrated as part of a comprehensive diabetes management plan, which also entails a balanced diet, routine physical activity, and weight management as instructed by a healthcare provider. Lifestyle choices significantly influence diabetes control. While some individuals may experience temporary side effects such as nausea, altered taste sensation, reduced appetite, bloating, stomach discomfort, diarrhea, or skin rash, these typically resolve swiftly. If these adverse effects persist or cause concern, it is vital to seek medical advice. This medication is contraindicated in cases of type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver diseases. Prior disclosure of any history of heart disease to the physician is crucial, as it may impact the suitability of this treatment. Pregnant and breastfeeding individuals should also engage in discussions with their healthcare provider before commencing therapy. Regular monitoring of blood glucose and possible laboratory assessments to evaluate blood cell counts and liver function may be necessary.